Golimumab is a prescription biologic medicine belonging to the tumor necrosis factor (TNF) inhibitor class. Simponi® (golimumab) 50 mg is supplied as a pre-filled injection for subcutaneous administration and is used under the supervision of a qualified healthcare professional.
For international pharmaceutical trade, biologic medicines such as golimumab require careful attention to product authorization, prescription requirements, temperature-controlled logistics, documentation, and destination-country regulations.
MEDINDIA EXPORT supports international pharmaceutical trade inquiries from buyers and distributors, subject to applicable Indian export regulations and the import requirements of the destination country.
Product Overview
| Product | Golimumab |
|---|---|
| Brand shown | Simponi® |
| Strength | 50 mg |
| Dosage form | Solution for injection |
| Administration | Subcutaneous |
| Product category | Biologic / TNF inhibitor |
| Prescription status | Prescription medicine |
| Storage | Follow the manufacturer's approved storage conditions |
| Packaging | Pre-filled syringe/approved presentation may vary by market |
Product availability, presentation, labeling, registration status, and packaging can differ between countries. Buyers should verify the exact market authorization and import requirements before placing an order.
International Pharmaceutical Trade Coverage
MEDINDIA EXPORT can receive legitimate B2B pharmaceutical inquiries from markets including:
United States, Canada, United Kingdom, Ireland, Germany, France, Italy, Spain, Portugal, Netherlands, Belgium, Luxembourg, Switzerland, Austria, Sweden, Norway, Denmark, Finland, Poland, Czech Republic, Slovakia, Hungary, Romania, Bulgaria, Greece, Croatia, Slovenia, Serbia, Australia, New Zealand, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Japan, South Korea, China, Hong Kong, Taiwan, United Arab Emirates, Saudi Arabia, Qatar, Kuwait, Bahrain, Oman, Jordan, Israel, South Africa, Nigeria, Kenya, Ghana, Tanzania, Uganda, Ethiopia, Egypt, Morocco, Algeria, Tunisia, Brazil, Mexico, Argentina, Chile, Colombia, Peru, Ecuador, Bolivia, Paraguay, Uruguay, Costa Rica, Panama, Guatemala, and other permitted international markets.
Import eligibility and regulatory requirements must always be confirmed for the specific destination country.
What International Buyers Should Check
Before importing a prescription biologic, buyers and authorized distributors should verify:
- Import authorization – Confirm whether the destination country permits the import of the specific product.
- Marketing authorization – Check whether the product is approved or otherwise legally importable in the destination market.
- Prescription requirements – Determine whether the medicine can be supplied only through licensed healthcare channels.
- Importer licensing – Confirm that the receiving company has the required pharmaceutical import/distribution licenses.
- Product documentation – Depending on the transaction, documentation may include commercial invoices, packing lists, certificates, product information, and other regulatory documents.
- Cold-chain requirements – Biologic medicines may require controlled-temperature transportation according to the manufacturer's approved specifications.
- Customs requirements – Verify HS classification, customs documentation, import duties, and local clearance requirements.
- Labeling requirements – Destination-country labeling and language requirements should be checked before shipment.
- Product authenticity – Buyers should source medicines through legitimate and appropriately licensed pharmaceutical channels.
- Local regulations – The importing country's medicines regulator and customs authority should be consulted before any shipment.
Pharmaceutical Export from India
India has an established pharmaceutical manufacturing and export ecosystem. However, international pharmaceutical transactions are subject to regulatory requirements in both the exporting and importing countries.
For prescription biologics such as golimumab, the transaction should be handled through authorized pharmaceutical businesses and licensed importers/distributors. Documentation, product registration, storage conditions, shipping procedures, and customs requirements should be confirmed before dispatch.
Trading FAQs
1. What is Golimumab 50 mg?
Golimumab is a monoclonal antibody that targets tumor necrosis factor (TNF). It is used for certain inflammatory conditions under medical supervision.
2. What is Simponi 50 mg?
Simponi is a brand of golimumab. The 50 mg presentation is available as a prescription injectable medicine, subject to market-specific authorization and packaging.
3. Is Golimumab a prescription medicine?
Yes. Golimumab is a prescription biologic medicine and should be supplied and used in accordance with applicable medical and pharmaceutical regulations.
4. Can Golimumab be exported from India?
Export eligibility depends on Indian export regulations, the specific product and documentation, and the import regulations of the destination country. Buyers should confirm regulatory eligibility before ordering.
5. Can every country import Golimumab?
No. Pharmaceutical import rules differ significantly between countries. A medicine that is authorized in one country may have different registration, import, labeling, or distribution requirements in another.
6. Does Golimumab require special transportation?
Biologic medicines may require controlled-temperature transportation. The manufacturer's approved storage and transportation conditions should be followed throughout the supply chain.
7. What documents may be required for pharmaceutical export?
Requirements vary according to the product and destination. Common commercial documents can include a commercial invoice, packing list, shipping documents, and relevant pharmaceutical or regulatory documentation.
8. Can an individual purchase Golimumab for international import?
International import of prescription biologics may be restricted or prohibited for individuals in many jurisdictions. Buyers should check their country's personal-import and prescription-medicine regulations before attempting to import the product.
9. Can distributors inquire about Golimumab?
Licensed pharmaceutical distributors, hospitals, healthcare organizations, and other eligible B2B buyers can contact MEDINDIA EXPORT to discuss legitimate international trade requirements, subject to applicable regulations.
10. How can buyers verify import eligibility?
The safest approach is to consult the destination country's medicines regulator, customs authority, and a licensed pharmaceutical importer or regulatory professional before placing an order.
Why Regulatory Compliance Matters
International pharmaceutical trade requires more than arranging transportation. Prescription biologics must move through an appropriate supply chain with attention to:
- Product authenticity
- Regulatory authorization
- Import licensing
- Temperature-controlled logistics where required
- Correct documentation
- Customs compliance
- Appropriate labeling
- Licensed distribution
- Destination-country pharmaceutical laws
Regulatory requirements can change, so buyers should obtain current guidance before every international transaction.
Contact MEDINDIA EXPORT
For legitimate B2B pharmaceutical export inquiries, product availability, documentation requirements, and destination-market trade questions:
Website: www.medicineindiaexport.com
Email: sales.medindiaexport@gmail.com
WhatsApp: +91 7218129896
MEDINDIA EXPORT — Pharmaceutical Export & International Trade Support from India
